Healthcare provider profile · identity verified

David Michael Wallace, M.D.

Family Practice · HAMPTON, VA · NPI 1134285810

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	424	152
Amlodipine Besylate	Amlodipine Besylate	276	109
Losartan Potassium	Losartan Potassium	166	66
Omeprazole	Omeprazole	147	48
Lisinopril	Lisinopril	141	52
Rosuvastatin Calcium	Rosuvastatin Calcium	133	49
Hydrochlorothiazide	Hydrochlorothiazide	123	51
Pantoprazole Sodium	Pantoprazole Sodium	118	47
Gabapentin	Gabapentin	107	41
Levothyroxine Sodium	Levothyroxine Sodium	106	35
Furosemide	Furosemide	104	40
Metformin Hcl	Metformin Hcl	103	36
Metoprolol Succinate	Metoprolol Succinate	100	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	98	34
Albuterol Sulfate Hfa	Albuterol Sulfate	96	36
Trazodone Hcl	Trazodone Hcl	87	34
Simvastatin	Simvastatin	83	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	25
Tamsulosin Hcl	Tamsulosin Hcl	79	34
Meloxicam	Meloxicam	76	42
Allopurinol	Allopurinol	74	22
Potassium Chloride	Potassium Chloride	73	24
Metoprolol Tartrate	Metoprolol Tartrate	72	24
Eliquis	Apixaban	68	19
Celecoxib	Celecoxib	66	23
Alendronate Sodium	Alendronate Sodium	64	20
Fluoxetine Hcl	Fluoxetine Hcl	62	21
Sertraline Hcl	Sertraline Hcl	60	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	21
Ezetimibe	Ezetimibe	57	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	20
Montelukast Sodium	Montelukast Sodium	56	19
Pravastatin Sodium	Pravastatin Sodium	53	20
Venlafaxine Hcl Er	Venlafaxine Hcl	53	14
Azelastine Hcl	Azelastine Hcl	52	33
Carvedilol	Carvedilol	52	20
Tramadol Hcl	Tramadol Hcl	50	17
Zolpidem Tartrate	Zolpidem Tartrate	50	13
Duloxetine Hcl	Duloxetine Hcl	47	25
Jardiance	Empagliflozin	47	15
Fluticasone Propionate	Fluticasone Propionate	45	19
Januvia	Sitagliptin Phosphate	45	12
Clopidogrel	Clopidogrel Bisulfate	44	18
Metformin Hcl Er	Metformin Hcl	42	18
Naproxen	Naproxen	41	13
Farxiga	Dapagliflozin Propanediol	40	11
Diclofenac Sodium	Diclofenac Sodium	38	17
Triamcinolone Acetonide	Triamcinolone Acetonide	38	24
Ibuprofen	Ibuprofen	37	18
Lorazepam	Lorazepam	37	suppressed
Synthroid	Levothyroxine Sodium	36	suppressed
Ozempic	Semaglutide	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	13
Glipizide Er	Glipizide	34	11
Baclofen	Baclofen	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	12
Spironolactone	Spironolactone	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	29
Fluconazole	Fluconazole	29	14
Mirtazapine	Mirtazapine	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	12
Pregabalin	Pregabalin	29	suppressed
Alprazolam	Alprazolam	27	suppressed
Atenolol	Atenolol	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	11
Benazepril Hcl	Benazepril Hcl	25	suppressed
Finasteride	Finasteride	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Eszopiclone	Eszopiclone	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Methylprednisolone	Methylprednisolone	22	18
Bupropion Xl	Bupropion Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	11
Topiramate	Topiramate	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	14
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Famotidine	Famotidine	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Nystatin	Nystatin	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	11
Valacyclovir	Valacyclovir Hcl	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Prednisone	Prednisone	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Valsartan	Valsartan	12	suppressed
Bimatoprost	Bimatoprost	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lactulose	Lactulose	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error